Clal Insurance Enterprises Holdings Ltd - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 66 filers reported holding UROGEN PHARMA LTD in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Clal Insurance Enterprises Holdings Ltd ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q3 2023$3,112
-43.2%
222,159
-58.0%
0.04%
-33.8%
Q2 2023$5,479
+12.0%
529,3880.0%0.06%
-11.0%
Q1 2023$4,892
+4.2%
529,3880.0%0.07%
+4.3%
Q4 2022$4,696
-99.9%
529,3880.0%0.07%
+16.7%
Q3 2022$4,405,000
+1.6%
529,3880.0%0.06%
+3.4%
Q2 2022$4,336,000
-6.0%
529,3880.0%0.06%
+18.4%
Q1 2022$4,611,000
-8.4%
529,3880.0%0.05%
-9.3%
Q4 2021$5,034,000
-43.5%
529,3880.0%0.05%
-47.1%
Q3 2021$8,904,000
+10.1%
529,3880.0%0.10%
+10.9%
Q2 2021$8,084,000
-21.6%
529,3880.0%0.09%
-22.7%
Q1 2021$10,312,000
+15.7%
529,3880.0%0.12%
-1.7%
Q4 2020$8,913,000
-12.7%
529,3880.0%0.12%
-29.7%
Q3 2020$10,212,000
-26.1%
529,3880.0%0.17%
-37.2%
Q2 2020$13,828,000
+46.4%
529,3880.0%0.27%
+16.1%
Q1 2020$9,444,000
-98.2%
529,388
+2896.6%
0.24%
-58.5%
Q4 2019$529,388,000
+4096.5%
17,666
-96.7%
0.57%
+85.0%
Q3 2019$12,615,000
-36.6%
529,388
-4.4%
0.31%
-33.0%
Q2 2019$19,903,000
-2.9%
553,778
-0.2%
0.46%
-8.8%
Q1 2019$20,501,000
+19.2%
554,974
+39.0%
0.50%
+12.3%
Q4 2018$17,192,000
+17.4%
399,262
+28.8%
0.45%
+14.9%
Q3 2018$14,641,000
-5.1%
310,0000.0%0.39%
-3.0%
Q2 2018$15,426,000
+9.5%
310,000
+9.3%
0.40%
+7.2%
Q1 2018$14,087,000
+8386.1%
283,500
+6255.1%
0.37%
+9250.0%
Q4 2017$166,0004,4610.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q4 2022
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 2,620,545$36,713,8356.69%
Wildcat Capital Management, LLC 495,606$6,943,4402.79%
SILVERARC CAPITAL MANAGEMENT, LLC 508,883$7,129,4512.16%
Opaleye Management Inc. 320,000$4,483,2001.46%
AlphaCentric Advisors LLC 165,000$2,311,6501.31%
Soleus Capital Management, L.P. 372,000$5,211,7200.48%
EAM Investors, LLC 170,523$2,389,0270.46%
RA Capital Management 1,483,697$20,786,5950.41%
Parkman Healthcare Partners LLC 145,311$2,035,8070.37%
MENORA MIVTACHIM HOLDINGS LTD. 2,303,031$32,265,4640.29%
View complete list of UROGEN PHARMA LTD shareholders